Carlsmed, Inc. (CARL) Stock Grade

About Carlsmed, Inc.'s fundamentals

Carlsmed is a medical device company with a market capitalization of $175.6 million that demonstrated strong revenue growth of 85.9% year-over-year, indicating rapidly expanding sales. However, the company operates at a significant loss, with a net margin of -59.8%, meaning it spent $0.60 in expenses for every dollar of revenue generated. The company reported a net loss in its latest annual statement and does not pay a dividend to shareholders. This profile reflects a growth-stage medical device company that is prioritizing revenue expansion while not yet achieving profitability.